Skip to main content

Cancer Survivorship Experts and Information for Media

St. Jude hosts the largest long-term, follow-up clinic for childhood cancer patients in the United States. Our investigators also maintain one of the world’s largest and longest-running studies which focuses on the long-term effects of cancer and its treatments. Our expert clinicians specialize in caring for survivors to learn about special health needs patients may have because of past cancers or treatments.

Learn more about childhood cancer survivorship and resources.

The following survivorship experts are available to offer credible information, hands-on expertise and clinical insight in cancer survivorship, long-term and late effects of cancer and its treatment and the evolution of cancer treatment.

To schedule interviews or speak with one of our experts, email media@stjude.org or contact one of our media relations staff.

Contact Media Relations

Cancer Survivorship Experts

  • Gregory T. Armstrong, MD, MSCE

    Greg Armstrong, MD, MSCE, is a member of the Department of Epidemiology and Cancer Control and the Childhood Cancer Survivor Study (CCSS) principle investigator at St. Jude Children's Research Hospital. The CCSS comprises of a multi-institutional study that has successfully followed more than 35,000 adult survivors of childhood cancer. Armstrong can provide considerable insight into many high-impact findings from CCSS, including studies that show how survivors of childhood cancer are living longer because of newer treatment protocols involving less chemotherapy and radiation for low-risk patients. He can also provide information about long-term cardiac outcomes in aging adult survivors of childhood cancer.

  • Melissa M. Hudson, MD

    Melissa Hudson, MD, is the Cancer Survivorship director and the After Completion of Therapy (ACT) Clinic co-leader at St. Jude Children’s Research Hospital. She can offer inight into the ACT Clinic, which monitors more than 8,000 long-term childhood cancer survivors treated on St. Jude trials. ACT serves as a paradigm of health promotion within a research setting that monitors complications, provides screening and prevention plans, and integrates the cancer experience with health care needs. Hudson can also provide information about her widely published research initiatives on pediatric Hodgkin’s lymphoma, which studied the after-effects of childhood cancer treatments and health education of childhood cancer survivors.

  • Kim E. Nichols, MD

    Kim Nichols, MD, is the Cancer Predisposition Division director at St. Jude Children’s Research Hospital. She is a pediatric oncologist interested in molecular mechanisms that protect against viral infections and cancer. Her research aims to learn how defects in these mechanisms contribute to disease and then use this information to develop more effective treatments for children with increased genetic risk for infection or malignancy. Nichols can also provide information on the psychological and behavioral impacts of cancer genetic testing of parents and their children.

  • Leslie L. Robison, PhD

    Les Robison, PhD, is the Department of Epidemiology and Cancer Control chair, the Cancer Control and Survivorship Program co-leader and the St. Jude Lifetime Cohort co-principle investigator. He also established the Childhood Cancer Survivor Study (CCSS), a multi-institutional study that has included more than 35,000 five-year survivors of childhood cancer diagnosed between 1970 and 1999. Robison can provide information on CCSS, which has led to significant institutional guidelines that have improved follow-up care for survivors of childhood cancers.  

Close